Clinical trial
PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
NCT00226005 · Pancreatic Cancer Research Team, Other · Completed
Key facts
| NCT number | NCT00226005 |
|---|---|
| Title | PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma |
| Official title | Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy. |
| Lead sponsor | Pancreatic Cancer Research Team, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm |
| Intervention type | Drug |
| Interventions | PTK787/ZK222584 |
| Enrollment | 67 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | Sep 26, 2005 |
| Last update posted | May 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: